Dr Connie Diakos
/content/dam/asset-migration/headshots/au-doctor-headshots/AU_Medical oncology_Headshot_GA_Dr Connie Diakos.jpg

Dr Connie Diakos

Dr Connie Diakos
Connie
Diakos
BSc (Hons) PhD MBBS FRACP, Medical Oncologist

Languages spoken

English

Overview

Centres

Frenchs Forest (Oncology)
Frenchs Forest (Oncology)

Suite 3, Level 1, Building 1, 49 Frenchs Forest Road, Frenchs Forest East NSW 2086

-33.75086268072276, 151.23993981919398
/au/our-centres/frenchs-forest
North Shore
North Shore

North Shore Health Hub, Tower A, Level 1, 7 Westbourne Street, St Leonards NSW 2065, Australia

-33.82024297423824, 151.19062046149045
/au/our-centres/north-shore

Specialises in

Breast Cancer
Condition
Condition/Cancer
Condition/Cancer/Breast Cancer
Gastrointestinal cancer
Condition
Condition/Cancer
Condition/Cancer/Gastrointestinal Cancer
Gynaecological cancer
Condition
Condition/Cancer
Condition/Cancer/Gynaecological Cancer

Treatments

Chemotherapy
Service
Service/Cancer
Service/Cancer/Medical Oncology
Service/Cancer/Medical Oncology/Chemotherapy
Radiation Oncology
Service
Service/Cancer
Service/Cancer/Radiation Oncology

Connie is an experienced medical oncologist specialising in gastrointestinal, breast, gynaecological, and neuroendocrine cancers.

Connie is an experienced medical oncologist specialising in gastrointestinal, breast, gynaecological, and neuroendocrine cancers.

Connie is a member of several cooperative trials’ groups and a senior research fellow in the Bill Walsh Translational Cancer Research Laboratory at the University of Sydney in the Kolling Institute. Her research focuses on identifying prognostic and predictive biomarkers of inflammation in patients with colorectal, ovarian, and other cancers. These markers can be used to help guide decision-making in treatment, predict the likely disease course and potential patient responses to treatment. Connie is dedicated to the education and training of the next generation of clinicians. She is a  conjoint senior lecturer at the University of Sydney and Co-Director of Training in the Department of Medical Oncology at Royal North Shore Hospital. Connie puts you, the patient, at the centre of her care by ensuring you are empowered with the right information to be part of the decision-making process for your treatment. As a patient in Connie’s care, you can be sure you are being treatment by an expert medical oncologist, working as part of a dedicated multidisciplinary team.

Research interests

Connie is passionate about research, because she believes it has the power to significantly improve people’s lives and outcomes. She encourages her patients to consider joining clinical trials where appropriate. Connie’s own research has been published extensively, and she actively applies her research insights to the care of her patients. In 2021, Connie was co-author of an article about the innovative use of scalp cooling technologies to reduce hair loss for women undergoing chemotherapy for breast cancer.

Professional memberships

  • MOGA
  • COSA
  • AGITG
  • ANZGOG
  • ESMO
  • ASCO
  • BCT
  • ENETS

Publications

  • Cancer-related inflammation and treatment effectiveness. C.I. Diakos, K.A. Charles, D.C. McMillan, S.J. Clarke. Lancet Oncology 2014; 15: e493-503.
  • A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis. F. Vafaee, C.I. Diakos, M.B. Kirschner, G. Reid, M. Michael, L.G. Horvath, Z.J. Cheng, Z. Kuncic, S.J. Clarke. npj Systems Biology and Applications 2018 4(1), 20.
  • The lymphocyte-to-monocyte ratio is a superior predictor of survival in comparison to established biomarkers of resectable colorectal cancer. J.C.Y. Chan, D.L. Chan, C.I. Diakos, A. Engel, N. Pavlakis, A. Gill, S.J. Clarke. Annals of Surgery 2017265(3), 539-546.
  • Tumour sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study. J.C.Y. Chan, C.I. Diakos, D.L. Chan, A. Engel, A. Gill, S.J. Clarke; PLOS One; 2019 14(6), e0218207.
  • A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial re-measurement. J.C.Y. Chan, C.I. Diakos, D.L. Chan, A. Engel, N. Pavlakis, A. Gill, S.J. Clarke. Annals of Surgery 2018267(6): 1119-1125.
  • Scalp cooling in integrated model of breast cancer care C. Diakos, S. Baron-Hay, L. Pugliano, E. Arnold, P. Mottlee, InSight +, May 2021.